Modified factor VIII

Details Modified factor VIII Modified factor VIII

1996-06-26

1999-01-12

Wax, Robert A.

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

435 691, 435 696, A61K 3514

Patent

active

058592040

ABSTRACT:
Site-specific replacement of amino acids in the region of positions 484-509 of human factor VIII can result in reduction of reactivity to an inhibitory antibody while procoagulant activity is retained. Modified human factor VIII having an immunoreactivity-reducing amino acid substituted for the naturally occurring amino acid is described.

REFERENCES:
patent: 4757006 (1988-07-01), Toole
patent: 4980456 (1990-12-01), Scandella et al.
patent: 5149637 (1992-09-01), Scandella et al.
patent: 5171844 (1992-12-01), Van Ooyen et al.
patent: 5364771 (1994-11-01), Lollar et al.
patent: 5422260 (1995-06-01), Kaufman et al.
patent: 5618788 (1997-04-01), Capon et al.
patent: 5618789 (1997-04-01), Capon et al.
patent: 5633150 (1997-05-01), Wood et al.
patent: 5663060 (1997-09-01), Lollar et al.
Gitschier, J. et al. (1984) Nature 312:326-330.
Toole, et al. (1986) Proc. Nat'l. Acad Sci. USA 83:5939-5942.
Lubin, et al. (1994) J. Biol. Chem. 269:8639-8641.
Church, et al. (1984) Proc. Nat. Acad. Sci. USA 81:6934.
Toole, et al. (1984) Nature 312:342-347.
Scandella, D. et al. (1995) Blood 86:1811-1819.

Affiliated with

Also associated with

Rating

Modified factor VIII does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified factor VIII, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified factor VIII will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1517583